¿ÀÆÛ°Ô½ÃÆÇ |
|
|
ÀÔ·ÂÀÏÀÚ: |
2015-02-11 |
À¯È¿ÀÏÀÚ: |
319460-85-0 |
Á¦ ¸ñ:
|
Axitinib |
»óÇ°ºÐ·ù: |
ÈÇкñ·á¿Í ³ó¾à |
µî·ÏºÐ·ù: |
Offer to Sell |
³» ¿ë: |
Axitinib
Synonyms: AXITINIB;Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;N-METHYL-2-{[3-((E)-2-PYRIDIN-2-YLVINYL)-1H-INDAZOL-6-YL]SULFANYL}BENZAMIDE;N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide;AVERMECTINB;Axitinib for research;AG 013736;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
CAS: 319460-85-0
MF: C22H18N4OS
MW: 386.47
Chemical Properties Off-White Solid
Usage A tyrosine kinase inhibitor; used in cancer therapy.
Usage Axitinib (AG-013736) is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR¥â and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.
Usage Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR¥â and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.
Usage Axitinib is a tyrosine kinase inhibitor. Axitinib is used in cancer therapy. |
¿¬¶ôó |
´ã
´ç ÀÚ: |
Ivy Young |
ȸ»çÁÖ¼Ò: |
No 496 Zhongshan Road, Wuhan City, Hubei Province, China 430064 |
¿ìÆí¹øÈ£: |
430064 |
ÀüȹøÈ£: |
86-027-50755963 |
Æѽº¹øÈ£:
|
86-027-50755963 |
E - mail: |
ycwlb045@yccreate.com |
|